Citi raises target price on EBOS Group, keeps 'neutral' rating

EBOS

18/08/2021 23:39

** Citi raises target price on Australian shares of medical
products marketer  EBO.AX  to A$31.5 from A$27.5 and maintains
"neutral" rating after upbeat full-year results
    ** Co on Wednesday said its full-year net profit after tax
attributable rose 14% to A$185.3 mln ($134.12 mln)  urn:newsml:reuters.com:*:nFWN2PO0RQ
    ** For EBO, "medium-term upside remains in M&A and capital
management given the balance sheet headroom" - Citi 
    ** Four of seven analysts rate the stock "buy" or higher,
three rate it "hold"; their median PT is A$31.25 – Refinitiv
data
    ** Stock has risen 15.4% this year, as of last close

($1 = 1.3816 Australian dollars)

 (Reporting by Soumyajit Saha in Bengaluru)
 ((Soumyajit.Saha@thomsonreuters.com;))